Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Survivors of Hodgkin lymphoma (HL) have an increased risk of subsequent malignant neoplasms (SMNs). Response-adapted treatment may decrease this risk by reducing exposure to therapy associated with SMN risk. The Children’s Oncology Group study AHOD0031 evaluated response-adapted therapy for children...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Giulino-Roth, Lisa, Pei, Qinglin, Buxton, Allen, Bush, Rizvan, Wu, Yue, Wolden, Suzanne L., Constine, Louis S., Kelly, Kara M., Schwartz, Cindy L., Friedman, Debra L.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2021
Materias:
Clinical Trials and Observations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7976513/
https://ncbi.nlm.nih.gov/pubmed/33512412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020007225
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares